OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...
OS Animal Health (OSAH), a wholly-owned subsidiary of OS Therapies (OSTX), targeting Initial Public Offering (IPO) on NYSE American or Nasdaq Capital Markets national stock exchange in the first half ...
M gross proceeds raised from pre-existing investors, providing capital runway into 2027All nine investors that were offered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback